Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds
June 2016
Recent guidelines will lead to more aggressive treatment of rheumatoid arthritis (RA) to suppress symptoms and slow joint damage.
Continue to recommend methotrexate first as the "anchor" drug.
If this isn't enough, suggest adding one or two other traditional disease-modifying antirheumatic drugs (DMARDs) such as sulfasalazine or hydroxychloroquine...or adding a biologic DMARD (Enbrel, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote